Elevance Health, Inc.
ELV- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001156039
In the last 90 days, Elevance Health, Inc. insiders filed 2 open-market purchases and 0 sales; 1,614 institutions reported holding it in 13F filings for Q2 2026, worth $76.8B in total; superinvestors Harris Associates (Oakmark) and Baupost Group hold it.
Superinvestors holding ELV, Q2 2026
2 superinvestors report holding Elevance Health, Inc. on Form 13F, worth $2.40B in total. Weight is Elevance Health, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Harris Associates (Oakmark)Bill Nygren | 2.5% | 4,924,511 | $1.90B | Added+2.7% |
| Baupost GroupSeth Klarman | 9.1% | 1,275,154 | $493.1M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ELV each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
2 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (+2.7%)
Q1 2026
2 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (0.0%), Baupost Group (+0.5%)
Q4 2025
2 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (+50.3%)
- Reduced
- Baupost Group (−3.8%)
Q3 2025
2 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (+39.4%), Baupost Group (+114.1%)
- Sold out
- D1 Capital Partners
Q2 2025
3 superinvestors holding at quarter end
- Added
- Harris Associates (Oakmark) (+0.3%), Baupost Group (+150.4%)
- Reduced
- D1 Capital Partners (−43.6%)
Q1 2025
3 superinvestors holding at quarter end
- New
- Baupost Group
- Added
- Harris Associates (Oakmark) (+25.2%)
- Reduced
- D1 Capital Partners (−27.6%)
Q4 2024
2 superinvestors holding at quarter end
Q3 2024
0 superinvestors holding at quarter end
- Sold out
- D1 Capital Partners
Q2 2024
1 superinvestor holding at quarter end
- Reduced
- D1 Capital Partners (−44.1%)
Q1 2024
1 superinvestor holding at quarter end
- Reduced
- D1 Capital Partners (−23.1%)
- Sold out
- Maverick Capital
Q4 2023
2 superinvestors holding at quarter end
- New
- Maverick Capital
- Reduced
- D1 Capital Partners (−28.2%)
- Sold out
- Gates Foundation Trust
Q3 2023
2 superinvestors holding at quarter end
- New
- Gates Foundation Trust
- Added
- D1 Capital Partners (+38.8%)
- Sold out
- Viking Global Investors, Maverick Capital
Q2 2023
3 superinvestors holding at quarter end
- New
- Maverick Capital
- Added
- D1 Capital Partners (+1.1%)
- Reduced
- Viking Global Investors (−34.4%)
Q1 2023
2 superinvestors holding at quarter end
- New
- D1 Capital Partners
- Added
- Viking Global Investors (+15.1%)
- Sold out
- Maverick Capital
Q4 2022
2 superinvestors holding at quarter end
- Reduced
- Viking Global Investors (−19.9%), Maverick Capital (−6.6%)
Q3 2022
2 superinvestors holding at quarter end
- New
- Maverick Capital
- Added
- Viking Global Investors (+59.6%)
Q2 2022
1 superinvestor holding at quarter end
- Added
- Viking Global Investors (+939.4%)
- Sold out
- Maverick Capital
Q1 2022
2 superinvestors holding at quarter end
- New
- Viking Global Investors
- Added
- Maverick Capital (+628.3%)
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−14.8%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−90.1%)
Q2 2021
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+3,077.5%)